: Diabetic foot ulcers represent an important economic burden for healthcare systems worldwide. We aimed to analyze the costs of care for diabetic foot ulcers (DFUs) associated with peripheral neuropathy (DPN) and peripheral arterial disease (PAD) and their trends in a tertiary-care hospital. : We used data from the electronic system of the Emergency Clinical County Hospital Cluj-Napoca, Romania. We included all episodes of hospitalization with a discharge date between 1 January 2015 and the 31 December 2018 and a discharge diagnosis of type 1 or type 2 diabetes, DPN, PAD, and foot ulcers. : During the analyzed period, 1094 episodes of hospitalization with type 1 or type 2 diabetes and DFUs were recorded. Of these, 25.9% had neuropathic, 47.1% ischemic, and 16.6% neuroischemic DFUs. The median length of hospital stay was 8.0 days, and the median cost per episode of hospitalization was 810.8 EUR, with no significant variations during the analyzed years. The cost per episode of hospitalization was higher in cases with ischemic DFUs than for other etiologies of foot ulcers for 2015-2017 ( < 0.001). In 2018, the costs for ischemic and neuroischemic DFUs were similar and significantly higher compared to neuropathic ones. Predictors of higher costs per episode of hospitalization included the etiology of the DFUs (β = 0.032, = 0.034) and the length of hospital stay (β = 0.860, < 0.001). : By analyzing data from a tertiary care hospital, we showed higher costs for the care of persons with ischemic DFU.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11855980 | PMC |
http://dx.doi.org/10.3390/jcm14041248 | DOI Listing |
Exp Clin Endocrinol Diabetes
March 2025
Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Diabetic foot ulcer (DFU) represents a severe complication of diabetes, mainly caused by peripheral vascular occlusion and infection, presenting significant clinical challenges in treatment and potentially resulting in gangrene, amputation, or even fatality. This study aimed to investigate the involvement and underlying mechanisms of Meteorin-like (Metrnl) in the pathogenic process of DFU. Mice underwent diabetes induction by streptozotocin, while human umbilical vein endothelial cells (HUVECs) were exposed to 5.
View Article and Find Full Text PDFCell Transplant
March 2025
Cardiovascular Research Unit, IRCCS MultiMedica, Milan, Italy.
Diabetic foot ulcers (DFUs) are associated with a high risk of amputations and a 50% 5-year survival rate due at least in part to the limited angiogenic and wound healing capacity of patients with diabetes. Cell therapy via intramuscular injection of peripheral blood mononuclear cells showed encouraging but limited results. Such limitations may arise from the limited ability of therapeutic cells to adhere to the target tissue.
View Article and Find Full Text PDFFront Microbiol
February 2025
Goethe University Frankfurt, University Hospital Frankfurt, Department II of Internal Medicine, Infectious Diseases, Frankfurt, Germany.
Diabetic foot ulcers (DFU) affect up to 15-25% of patients suffering from diabetes and are considered a global health concern. These ulcers may result in delayed wound healing and chronic infections, with the potential to lead to amputations. It has been estimated that 85% of diabetes-related amputations are preceded by a diagnosis of DFU.
View Article and Find Full Text PDFCureus
February 2025
General Medicine, SVS Medical College, Mahabubnagar, IND.
Diabetic foot ulcers (DFUs) are severe complications of diabetes mellitus that often lead to nontraumatic limb amputation. This systematic review aimed to assess the primary clinical evidence supporting hyperbaric oxygen therapy (HBOT) in the management of DFUs. A literature search was conducted using PubMed, Scopus, and Web of Science from June to August 2024, and six studies with a total of 391 patients were included in the final analysis, after applying relevant inclusion and exclusion criteria.
View Article and Find Full Text PDFJ Pharm Bioallied Sci
December 2024
Department of Nursing, Government Erode Medical College and Hospital, Affiliated Under The Tamil Nadu Dr MGR Medical University, Chennai, Tamil Nadu, India.
Background: Diabetes mellitus has emerged as a global health crisis, with its prevalence escalating dramatically. Diabetic peripheral neuropathy (DPN) stands out as one of the most frequent complications, leading to significant morbidity, including foot ulcers and amputations, if not identified and managed promptly. Effective screening methods are essential for early detection, which can significantly improve patient outcomes and reduce the risk of severe complications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!